Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
STAT3 Transcription Factor | 3 | 2022 | 870 | 0.980 |
Why?
|
Glucuronidase | 1 | 2024 | 203 | 0.820 |
Why?
|
Gryllidae | 4 | 2024 | 20 | 0.740 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2024 | 702 | 0.670 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2023 | 637 | 0.650 |
Why?
|
Graphite | 3 | 2024 | 79 | 0.650 |
Why?
|
Pericytes | 1 | 2022 | 299 | 0.640 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2024 | 1118 | 0.620 |
Why?
|
Acute Kidney Injury | 4 | 2022 | 1946 | 0.600 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2024 | 1499 | 0.580 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2022 | 426 | 0.570 |
Why?
|
Kidney | 8 | 2023 | 7066 | 0.540 |
Why?
|
Fibrosis | 7 | 2024 | 2070 | 0.520 |
Why?
|
Ear | 1 | 2015 | 172 | 0.480 |
Why?
|
Cicatrix, Hypertrophic | 1 | 2015 | 80 | 0.470 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2024 | 2310 | 0.440 |
Why?
|
Fibrinogen | 3 | 2014 | 895 | 0.420 |
Why?
|
Kidney Diseases | 5 | 2016 | 2098 | 0.420 |
Why?
|
Cyclin-Dependent Kinase 5 | 2 | 2010 | 110 | 0.410 |
Why?
|
Reperfusion Injury | 3 | 2013 | 1042 | 0.380 |
Why?
|
Receptors, Virus | 1 | 2013 | 651 | 0.340 |
Why?
|
Interleukins | 3 | 2022 | 791 | 0.330 |
Why?
|
Adipocytes | 1 | 2015 | 1194 | 0.310 |
Why?
|
Protein Phosphatase 2 | 1 | 2010 | 230 | 0.300 |
Why?
|
Atherosclerosis | 1 | 2024 | 3424 | 0.300 |
Why?
|
Amide Synthases | 1 | 2007 | 14 | 0.290 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 1612 | 0.280 |
Why?
|
Apoptosis | 7 | 2024 | 9514 | 0.280 |
Why?
|
Electrochemistry | 1 | 2007 | 142 | 0.280 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2017 | 2942 | 0.270 |
Why?
|
Alcohol Dehydrogenase | 1 | 2007 | 113 | 0.270 |
Why?
|
Kidney Tubules, Proximal | 3 | 2024 | 386 | 0.270 |
Why?
|
Protein Kinases | 1 | 2013 | 1611 | 0.270 |
Why?
|
Autophagy | 2 | 2024 | 1351 | 0.250 |
Why?
|
Heterozygote | 1 | 2012 | 2794 | 0.250 |
Why?
|
Aristolochic Acids | 1 | 2024 | 13 | 0.240 |
Why?
|
Cell Transdifferentiation | 2 | 2024 | 186 | 0.230 |
Why?
|
MicroRNAs | 4 | 2023 | 3785 | 0.230 |
Why?
|
Nanodiamonds | 1 | 2023 | 2 | 0.230 |
Why?
|
Carboplatin | 4 | 2008 | 789 | 0.220 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2024 | 292 | 0.210 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 2 | 2022 | 820 | 0.210 |
Why?
|
Mice, Inbred C57BL | 11 | 2024 | 22332 | 0.210 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2024 | 474 | 0.210 |
Why?
|
Membrane Glycoproteins | 1 | 2013 | 3690 | 0.200 |
Why?
|
Asparagine | 1 | 2023 | 120 | 0.200 |
Why?
|
Stem Cells | 1 | 2015 | 3540 | 0.200 |
Why?
|
Bystander Effect | 2 | 2015 | 90 | 0.200 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2024 | 479 | 0.200 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2022 | 17 | 0.200 |
Why?
|
Nanoparticles | 2 | 2024 | 1964 | 0.200 |
Why?
|
Cell Cycle | 1 | 2010 | 2920 | 0.200 |
Why?
|
Mitomycin | 2 | 2015 | 261 | 0.200 |
Why?
|
Smad7 Protein | 2 | 2019 | 39 | 0.190 |
Why?
|
Animals | 29 | 2024 | 168764 | 0.180 |
Why?
|
Biosensing Techniques | 1 | 2007 | 642 | 0.180 |
Why?
|
Ethanol | 1 | 2007 | 1323 | 0.180 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2022 | 615 | 0.170 |
Why?
|
Mice | 18 | 2024 | 81819 | 0.170 |
Why?
|
Arthritis, Experimental | 1 | 2022 | 288 | 0.170 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2024 | 752 | 0.160 |
Why?
|
Polycystic Kidney Diseases | 1 | 2020 | 133 | 0.160 |
Why?
|
Mice, Knockout | 6 | 2022 | 14448 | 0.160 |
Why?
|
MAP Kinase Signaling System | 2 | 2024 | 1490 | 0.160 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 2020 | 166 | 0.160 |
Why?
|
Signal Transduction | 6 | 2024 | 23601 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2024 | 2453 | 0.150 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2022 | 1333 | 0.150 |
Why?
|
Aortic Diseases | 1 | 2024 | 729 | 0.150 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2018 | 190 | 0.140 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2024 | 2878 | 0.140 |
Why?
|
Cells, Cultured | 6 | 2024 | 18973 | 0.140 |
Why?
|
Transforming Growth Factor beta | 1 | 2024 | 1995 | 0.130 |
Why?
|
Aorta | 1 | 2024 | 2028 | 0.130 |
Why?
|
Drug Design | 2 | 2018 | 1042 | 0.130 |
Why?
|
Cell Proliferation | 7 | 2024 | 10429 | 0.130 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2023 | 1314 | 0.130 |
Why?
|
Mice, Inbred BALB C | 5 | 2021 | 6220 | 0.130 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2016 | 68 | 0.130 |
Why?
|
Rats, Wistar | 3 | 2018 | 1884 | 0.130 |
Why?
|
Autoimmunity | 2 | 2022 | 1354 | 0.120 |
Why?
|
Lupus Nephritis | 1 | 2019 | 320 | 0.120 |
Why?
|
Macrophages | 4 | 2019 | 5772 | 0.120 |
Why?
|
Cell Death | 2 | 2019 | 1679 | 0.120 |
Why?
|
Toxicity Tests | 1 | 2015 | 111 | 0.120 |
Why?
|
DNA Damage | 4 | 2022 | 2457 | 0.120 |
Why?
|
Cysts | 1 | 2020 | 684 | 0.120 |
Why?
|
Longevity | 1 | 2022 | 1087 | 0.120 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1624 | 0.120 |
Why?
|
Cell Survival | 4 | 2019 | 5747 | 0.110 |
Why?
|
Primary Graft Dysfunction | 1 | 2015 | 112 | 0.110 |
Why?
|
Diabetic Nephropathies | 1 | 2021 | 969 | 0.110 |
Why?
|
Hedgehog Proteins | 1 | 2018 | 774 | 0.110 |
Why?
|
Environmental Pollutants | 1 | 2023 | 1290 | 0.110 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2022 | 3797 | 0.110 |
Why?
|
Th17 Cells | 2 | 2022 | 786 | 0.110 |
Why?
|
RNA, Messenger | 4 | 2018 | 12768 | 0.110 |
Why?
|
Fatty Acids | 1 | 2021 | 1806 | 0.110 |
Why?
|
Heme Oxygenase-1 | 1 | 2015 | 364 | 0.100 |
Why?
|
RNA, Small Interfering | 4 | 2021 | 3421 | 0.100 |
Why?
|
Inflammation | 3 | 2022 | 10850 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2018 | 2329 | 0.100 |
Why?
|
Phosphorylation | 3 | 2013 | 8278 | 0.100 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6942 | 0.100 |
Why?
|
Protein Biosynthesis | 2 | 2016 | 2086 | 0.100 |
Why?
|
Fluorouracil | 2 | 2007 | 1648 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2015 | 2047 | 0.090 |
Why?
|
Coordination Complexes | 1 | 2011 | 73 | 0.090 |
Why?
|
Intestines | 1 | 2019 | 1906 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 2 | 2012 | 2476 | 0.090 |
Why?
|
Glucose Transporter Type 4 | 1 | 2010 | 240 | 0.090 |
Why?
|
Pharmaceutical Preparations | 1 | 1998 | 1084 | 0.090 |
Why?
|
Bayes Theorem | 1 | 1998 | 2354 | 0.090 |
Why?
|
Disease Models, Animal | 3 | 2024 | 18293 | 0.080 |
Why?
|
Cell Line | 3 | 2024 | 15543 | 0.080 |
Why?
|
Caveolin 1 | 1 | 2011 | 255 | 0.080 |
Why?
|
Monocytes | 1 | 2019 | 2595 | 0.080 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2011 | 428 | 0.080 |
Why?
|
Liver Neoplasms | 2 | 2018 | 4353 | 0.080 |
Why?
|
Protein Binding | 3 | 2022 | 9296 | 0.080 |
Why?
|
Copper | 1 | 2011 | 367 | 0.080 |
Why?
|
Antineoplastic Agents | 5 | 2018 | 13648 | 0.080 |
Why?
|
In Situ Hybridization | 1 | 2012 | 1886 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3111 | 0.080 |
Why?
|
DNA Primers | 1 | 2012 | 2825 | 0.070 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 612 | 0.070 |
Why?
|
Sequence Analysis, RNA | 1 | 2015 | 2034 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2822 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1874 | 0.070 |
Why?
|
Blotting, Western | 2 | 2012 | 5020 | 0.070 |
Why?
|
Humans | 30 | 2024 | 765968 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2022 | 3213 | 0.070 |
Why?
|
Miniaturization | 1 | 2007 | 150 | 0.070 |
Why?
|
Receptor, Insulin | 1 | 2010 | 837 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2022 | 3733 | 0.070 |
Why?
|
Adjuvants, Pharmaceutic | 1 | 2006 | 48 | 0.070 |
Why?
|
Electric Conductivity | 1 | 2007 | 403 | 0.070 |
Why?
|
beta-Cyclodextrins | 1 | 2006 | 66 | 0.060 |
Why?
|
Plasmids | 1 | 2011 | 2274 | 0.060 |
Why?
|
Base Sequence | 2 | 2015 | 12403 | 0.060 |
Why?
|
Kidney Tubules | 2 | 2019 | 453 | 0.060 |
Why?
|
Papillomaviridae | 2 | 2011 | 1141 | 0.060 |
Why?
|
Equipment Failure Analysis | 1 | 2007 | 834 | 0.060 |
Why?
|
Rats | 3 | 2018 | 23707 | 0.060 |
Why?
|
Mice, Transgenic | 3 | 2023 | 9550 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4392 | 0.050 |
Why?
|
Antitubercular Agents | 1 | 2012 | 1384 | 0.050 |
Why?
|
Larva | 1 | 2024 | 511 | 0.050 |
Why?
|
Databases, Factual | 1 | 1998 | 8067 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2013 | 3141 | 0.050 |
Why?
|
Tumor Microenvironment | 1 | 2015 | 3946 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5786 | 0.050 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2022 | 178 | 0.050 |
Why?
|
Coumarins | 1 | 2022 | 120 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2022 | 11641 | 0.050 |
Why?
|
Cell Line, Tumor | 7 | 2018 | 17075 | 0.050 |
Why?
|
Interleukin-17 | 2 | 2021 | 921 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2010 | 3737 | 0.050 |
Why?
|
Disease Progression | 3 | 2019 | 13632 | 0.050 |
Why?
|
Caco-2 Cells | 1 | 2022 | 366 | 0.050 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2022 | 182 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5337 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8730 | 0.050 |
Why?
|
Computational Biology | 1 | 2013 | 3559 | 0.050 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2021 | 32 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 6 | 1 | 2021 | 59 | 0.050 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2022 | 323 | 0.040 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2022 | 368 | 0.040 |
Why?
|
Male | 10 | 2024 | 363698 | 0.040 |
Why?
|
Palmitic Acid | 1 | 2021 | 147 | 0.040 |
Why?
|
Serum Albumin, Bovine | 1 | 2021 | 318 | 0.040 |
Why?
|
Molecular Conformation | 2 | 2012 | 541 | 0.040 |
Why?
|
Antigens, CD | 1 | 2010 | 4025 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2015 | 4270 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 11888 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2022 | 698 | 0.040 |
Why?
|
RNA Interference | 2 | 2021 | 2832 | 0.040 |
Why?
|
Neoplasms | 3 | 2018 | 22340 | 0.040 |
Why?
|
TRPP Cation Channels | 1 | 2020 | 177 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2022 | 431 | 0.040 |
Why?
|
Pyridines | 1 | 2011 | 2888 | 0.040 |
Why?
|
Single-Cell Analysis | 1 | 2010 | 2535 | 0.040 |
Why?
|
Diethylnitrosamine | 1 | 2018 | 45 | 0.040 |
Why?
|
Equipment Design | 1 | 2007 | 3481 | 0.040 |
Why?
|
Tuberculosis | 1 | 2012 | 2012 | 0.040 |
Why?
|
Oncogene Protein v-akt | 2 | 2011 | 130 | 0.040 |
Why?
|
Plaque, Amyloid | 1 | 2023 | 772 | 0.040 |
Why?
|
Synovial Membrane | 1 | 2022 | 513 | 0.040 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2019 | 159 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2011 | 5125 | 0.040 |
Why?
|
Epithelial Cells | 2 | 2024 | 3681 | 0.040 |
Why?
|
Sulfones | 1 | 2021 | 447 | 0.040 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 115 | 0.040 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2018 | 186 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2023 | 3051 | 0.030 |
Why?
|
Th1 Cells | 1 | 2022 | 1039 | 0.030 |
Why?
|
Endocytosis | 1 | 2021 | 951 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 8611 | 0.030 |
Why?
|
Cilia | 1 | 2020 | 499 | 0.030 |
Why?
|
HeLa Cells | 2 | 2015 | 3067 | 0.030 |
Why?
|
Leupeptins | 1 | 2015 | 112 | 0.030 |
Why?
|
Macromolecular Substances | 1 | 2018 | 1430 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2007 | 3430 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2009 | 720 | 0.030 |
Why?
|
Carcinoma | 1 | 2006 | 2312 | 0.030 |
Why?
|
Benzamides | 1 | 2021 | 1377 | 0.030 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 2015 | 94 | 0.030 |
Why?
|
Kinetics | 1 | 2023 | 6274 | 0.030 |
Why?
|
Fas Ligand Protein | 1 | 2015 | 214 | 0.030 |
Why?
|
Papillomavirus Infections | 1 | 2007 | 1640 | 0.030 |
Why?
|
Ancrod | 1 | 2014 | 7 | 0.030 |
Why?
|
DNA | 2 | 2023 | 7202 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3160 | 0.030 |
Why?
|
Green Fluorescent Proteins | 2 | 2010 | 2060 | 0.030 |
Why?
|
Chemokines | 1 | 2019 | 956 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 1 | 2015 | 610 | 0.030 |
Why?
|
Species Specificity | 1 | 2019 | 2406 | 0.030 |
Why?
|
Microglia | 1 | 2023 | 1372 | 0.030 |
Why?
|
Smad2 Protein | 1 | 2014 | 144 | 0.030 |
Why?
|
beta Catenin | 1 | 2018 | 1043 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2056 | 0.030 |
Why?
|
DNA Repair | 1 | 2022 | 2048 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9443 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2014 | 379 | 0.030 |
Why?
|
PPAR gamma | 1 | 2015 | 483 | 0.030 |
Why?
|
Colitis | 1 | 2021 | 1239 | 0.030 |
Why?
|
Melanoma | 1 | 2011 | 5719 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2007 | 5783 | 0.020 |
Why?
|
Ureteral Obstruction | 1 | 2014 | 291 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 2018 | 1415 | 0.020 |
Why?
|
Enzyme Activation | 2 | 2008 | 3586 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14652 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3513 | 0.020 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2011 | 204 | 0.020 |
Why?
|
Trigonella | 1 | 2010 | 3 | 0.020 |
Why?
|
Cytochalasin B | 1 | 2010 | 74 | 0.020 |
Why?
|
Mitochondria | 1 | 2024 | 3673 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2015 | 1837 | 0.020 |
Why?
|
DNA Cleavage | 1 | 2011 | 56 | 0.020 |
Why?
|
Insulin Antagonists | 1 | 2010 | 17 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4241 | 0.020 |
Why?
|
Genistein | 1 | 2010 | 87 | 0.020 |
Why?
|
Mice, SCID | 1 | 2015 | 2630 | 0.020 |
Why?
|
Microscopy, Video | 1 | 2010 | 241 | 0.020 |
Why?
|
Doxorubicin | 1 | 2017 | 2230 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2008 | 21056 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2007 | 1410 | 0.020 |
Why?
|
Receptors, Death Domain | 1 | 2009 | 31 | 0.020 |
Why?
|
Tumor Stem Cell Assay | 1 | 2009 | 116 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2023 | 3896 | 0.020 |
Why?
|
Female | 10 | 2024 | 396112 | 0.020 |
Why?
|
Genetic Markers | 1 | 2015 | 2601 | 0.020 |
Why?
|
Edetic Acid | 1 | 2009 | 274 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2007 | 20124 | 0.020 |
Why?
|
Adipokines | 1 | 2011 | 308 | 0.020 |
Why?
|
Androstadienes | 1 | 2010 | 347 | 0.020 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 2008 | 220 | 0.020 |
Why?
|
Cricetulus | 1 | 2010 | 805 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2022 | 4913 | 0.020 |
Why?
|
Obesity | 1 | 2011 | 13076 | 0.020 |
Why?
|
CHO Cells | 1 | 2010 | 1372 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2011 | 558 | 0.020 |
Why?
|
Culture Media | 1 | 2009 | 890 | 0.020 |
Why?
|
Plant Extracts | 1 | 2010 | 496 | 0.020 |
Why?
|
Cricetinae | 1 | 2010 | 2411 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4260 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2011 | 1947 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2008 | 870 | 0.020 |
Why?
|
Binding Sites | 1 | 2015 | 6001 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10729 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2009 | 1336 | 0.020 |
Why?
|
Cell Count | 1 | 2009 | 1823 | 0.020 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2007 | 429 | 0.010 |
Why?
|
Protein Transport | 1 | 2010 | 1939 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2010 | 1966 | 0.010 |
Why?
|
Liver | 1 | 2020 | 7562 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2014 | 3222 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2627 | 0.010 |
Why?
|
Transfection | 1 | 2011 | 5743 | 0.010 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2007 | 647 | 0.010 |
Why?
|
Ligands | 1 | 2009 | 3273 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7584 | 0.010 |
Why?
|
Up-Regulation | 1 | 2011 | 4137 | 0.010 |
Why?
|
Time Factors | 1 | 2023 | 40065 | 0.010 |
Why?
|
Weight Gain | 1 | 2011 | 2355 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2006 | 1744 | 0.010 |
Why?
|
Middle Aged | 3 | 2024 | 223009 | 0.010 |
Why?
|
Cell Membrane | 1 | 2009 | 3634 | 0.010 |
Why?
|
Lipids | 1 | 2011 | 3315 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4562 | 0.010 |
Why?
|
Drug Combinations | 1 | 2006 | 2077 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2011 | 13400 | 0.010 |
Why?
|
Down-Regulation | 1 | 2006 | 2927 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 17594 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2010 | 3110 | 0.010 |
Why?
|
NF-kappa B | 1 | 2006 | 2485 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 24282 | 0.010 |
Why?
|
Insulin | 1 | 2010 | 6599 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 59489 | 0.010 |
Why?
|
Aged | 2 | 2018 | 171117 | 0.010 |
Why?
|
Adult | 1 | 2018 | 223044 | 0.000 |
Why?
|